Jennison Associates’s CONMED CNMD Stock Holding History
Bought
Maintained
Sold
Other funds holding CNMD
CB
Jennison Associates's CNMD Position: Q4 2025 in Review
Jennison Associates sold out of CONMED (CNMD) in Q4 2025, closing a stake of 19,960 shares — an estimated $939K sold.
Jennison Associates first reported a position in CNMD in Q4 2019 and held it in 13 quarters. The position peaked at $66.3M in Q2 2023. 265 funds tracked by Wall St. Rank hold CNMD as of Q4 2025.
- Jennison Associates reported no remaining CONMED position as of Q4 2025 after selling out during the quarter.
- Jennison Associates sold 19,960 CONMED shares in Q4 2025, an estimated $939K.
- Jennison Associates first reported a position in CONMED in Q4 2019 and held it in 13 quarters.
- Jennison Associates's CONMED position peaked at $66.3M in Q2 2023.
- 265 funds tracked by Wall St. Rank held CONMED as of Q4 2025.
Based on Jennison Associates's 13F filing for Q4 2025, filed 30 Jan 2026.